The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Novel Proteinaceous Infectious Particles Cause Scrapie
Abstract
After infection and a prolonged incubation period, the scrapie agent causes a degenerative disease of the central nervous system in sheep and goats. Six lines of evidence including sensitivity to proteases demonstrate that this agent contains a protein that is required for infectivity. Although the scrapie agent is irreversibly inactivated by alkali, five procedures with more specificity for modifying nucleic acids failed to cause inactivation. The agent shows heterogeneity with respect to size, apparently a result of its hydrophobicity; the smallest form may have a molecular weight of 50,000 or less. Because the novel properties of the scrapie agent distinguish it from viruses, plasmids, and viroids, a new term "prion" is proposed to denote a small pro teinaceous in fectious particle which is resistant to inactivation by most procedures that modify nucleic acids. Knowledge of the scrapie agent structure may have significance for understanding the causes of several degenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Physical chemistry of macromolecules
(2007) · Choice Reviews Online · doi:10.5860/choice.45-2038 · Cited by 3,765
Central Dogma of Molecular Biology
CRICK, F. (1970) · Nature · doi:10.1038/227561a0 · Cited by 3,444
Szoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
Nature of the Scrapie Agent: Self-replication and Scrapie
GRIFFITH, J. S. (1967) · Nature · doi:10.1038/2151043a0 · Cited by 1,161
Experimental Transmission of a Kuru-like Syndrome to Chimpanzees
GAJDUSEK, D. C., GIBBS, C. J., & ALPERS, M. (1966) · Nature · doi:10.1038/209794a0 · Cited by 837
FURTHER STUDIES ON THE ALKYLATION OF NUCLEIC ACIDS AND THEIR CONSTITUENT NUCLEOTIDES
LAWLEY, P., & BROOKES, P. (1963) · Biochemical Journal · doi:10.1042/bj0890127 · Cited by 797
Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee
Gibbs, C. J., Gajdusek, D. C., Asher, D. M., Alpers, M. P., Beck, E., Daniel, P. M., & Matthews, W. B. (1968) · Science · doi:10.1126/science.161.3839.388 · Cited by 779
Does the Agent of Scrapie Replicate without Nucleic Acid ?
ALPER, T., CRAMP, W. A., HAIG, D. A., & CLARKE, M. C. (1967) · Nature · doi:10.1038/214764a0 · Cited by 691
Unconventional Viruses and the Origin and Disappearance of Kuru
Gajdusek, D. C. (1977) · Science · doi:10.1126/science.142303 · Cited by 671
Research works printed but not linked: 88
- CAN MED ASS J 124: 1436 (1981).
- ADAMS, D.H., BIOCH SOC T 1: 1061 (1973). · doi:10.1042/bst0011061
- ADAMS, D.H., BRITISH MEDICAL JOURNAL 3: 1973 (1967).
- ADAMS, D.H., NATURE OF SCRAPIE AGENT - A REVIEW OF RECENT PROGRESS, PATHOLOGIE BIOLOGIE 18: 559 (1970).
- ALPERS, M, SLOW TRANSMISSIBLE D 1: 67 (1979).
- ANDREWS, P, METHODS OF BIOCHEMICAL ANALYSIS 18: 1 (1971).
- BARINGER, J.R., REGIONAL NEUROPATHOLOGY AND TITERS IN HAMSTER SCRAPIE, JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 40: 329 (1981).
- BASTIAN, F.O., SPIROPLASMA-LIKE INCLUSIONS IN CREUTZFELDT-JAKOB DISEASE, ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 103: 665 (1979).
- BASTIAN, F.O., ADDITIONAL EVIDENCE OF SPIROPLASMA IN CREUTZFELDT-JAKOB DISEASE, LANCET 1: 660 (1981).
- BISHOP, J.M., ENEMIES WITHIN - THE GENESIS OF RETROVIRUS ONCOGENES, CELL 23: 5 (1981). · doi:10.1016/0092-8674(81)90263-4
- BORNSTEIN, P, SPECIFIC NONENZYMATIC CLEAVAGE OF BOVINE RIBONUCLEASE WITH HYDROXYLAMINE, JOURNAL OF BIOLOGICAL CHEMISTRY 245: 4854 (1970). · doi:10.1016/s0021-9258(18)62873-x
- Borrás, M.-T., Journal of General Virology 58: 263 (1982). · doi:10.1099/0022-1317-58-2-263
- BROWN, D.M., BASIC PRINCIPLES NUC 2: 1 (1974).
- BROWN, P, EFFECT OF DIFFERENT GRADIENT SOLUTIONS ON BUOYANT DENSITY OF SCRAPIE INFECTIVITY, PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 158: 513 (1978). · doi:10.3181/00379727-158-40236
- CHO, H.J., IS SCRAPIE AGENT A VIRUS, NATURE 262: 411 (1976). · doi:10.1038/262411a0
- CRAIG, R, THE THEORETICAL POSSIBILITY OF REVERSE TRANSLATION OF PROTEINS INTO GENES, JOURNAL OF THEORETICAL BIOLOGY 88: 757 (1981). · doi:10.1016/0022-5193(81)90250-2
- CUILLE, J, COMPTES RENDUS HEBDOMADAIRES DES SEANCES DE L'ACADEMIE DES SCIENCES 208: 1058 (1939).
- DARLINGTON, C.D., VIRUS DISEASES NERVO: 133 (1969).
- DICKINSON, A.G., GENETICAL CONTROL OF CONCENTRATION OF ME7 SCRAPIE AGENT IN BRAIN OF MICE, JOURNAL OF COMPARATIVE PATHOLOGY 79: 15 (1969). · doi:10.1016/0021-9975(69)90021-8
- DICKINSON, A.G., GENETICAL CONTROL OF CONCENTRATION OF ME7 SCRAPIE AGENT IN MOUSE SPLEEN, JOURNAL OF COMPARATIVE PATHOLOGY 79: 363 (1969). · doi:10.1016/0021-9975(69)90051-6
- DICKINSON, A.G., SLOW TRANSMISSIBLE D 1: 367 (1979).
- DICKINSON, A.G., SLOW VIRUS INFECTION: 3 (1977).
- DIENER, T.O., IS SCRAPIE AGENT A VIROID, NATURE-NEW BIOLOGY 235: 218 (1972).
- DIENER T.O. VIROIDS VIROID DISEA (1979). · doi:10.1016/b978-0-12-601950-6.50015-4
- FIELD, E.J., TRANSMISSION EXPERIMENTS WITH MULTIPLE SCLEROSIS - AN INTERIM REPORT, BRITISH MEDICAL JOURNAL 2: 564 (1966). · doi:10.1136/bmj.2.5513.564
- FIELD, E.J., DT Z NERVENHEILKUNDE 192: 265 (1967).
- FRANKLIN, R.M., INACTIVATION OF SOME ANIMAL VIRUSES BY HYDROXYLAMINE AND THE STRUCTURE OF RIBONUCLEIC ACID, NATURE 184: 343 (1959). · doi:10.1038/184343a0
- FREESE, E, HYDROXYLAMINE AS A MUTAGENIC AND INACTIVATING AGENT, JOURNAL OF MOLECULAR BIOLOGY 3: 133 (1961). · doi:10.1016/s0022-2836(61)80040-5
- GAJDUSEK, D.C., HUMAN DISEASES CAUSE: 231 (1978).
- GAJDUSEK, D.C., VIRUSES ENV: 79 (1978).
- GIANNONI, G, CRYSTALLIZATION OF DNA FROM DILUTE SOLUTION, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 62: 964 (1969).
- GIBBS, C.J., SLOW TRANSMISSIBLE D 2: 87 (1979).
- GORDON, W.S., VETERINARY RECORD 69: 1444 (1957).
- GORDON, W.S., VETERINARY RECORD 58: 516 (1946).
- GRAY, A, SPIROPLASMA AND CREUTZFELDT-JAKOB DISEASE, LANCET 2: 152 (1980).
- HAASE, A.T., INFECTIVITY OF VISNA VIRUS DNA, VIROLOGY 70: 65 (1976). · doi:10.1016/0042-6822(76)90236-1
- HADLOW, W.J., SCRAPIE AND KURU, LANCET 2: 289 (1959).
- HADLOW, W.J., VIROLOGIC AND NEUROHISTOLOGIC FINDINGS IN DAIRY GOATS AFFECTED WITH NATURAL SCRAPIE, VETERINARY PATHOLOGY 17: 187 (1980). · doi:10.1177/030098588001700207
- HAIG, D.A., SLOW LATENT TEMPERAT 2: 215 (1965).
- HOGAN, R.N., PROGRESSIVE RETINAL DEGENERATION IN SCRAPIE-INFECTED HAMSTERS - A LIGHT AND ELECTRON-MICROSCOPIC ANALYSIS, LABORATORY INVESTIGATION 44: 34 (1981).
- HUNTER, G.D., VIRAL AND NON-VIRAL PROPERTIES OF SCRAPIE AGENT, ANNALS OF CLINICAL RESEARCH 5: 262 (1973).
- HUNTER, G.D., ATTEMPTS TO RELEASE SCRAPIE AGENT FROM TISSUE DEBRIS, JOURNAL OF COMPARATIVE PATHOLOGY 77: 301 (1967). · doi:10.1016/0021-9975(67)90039-4
- HUNTER, G.D., SLOW TRANSMISSIBLE D 2: 365 (1979).
- KIMBERLIN, R.H., J GEN VIROL 1: 115 (1967).
- KIMBERLIN, R.H., EXPERIMENTAL SCRAPIE IN MOUSE - REVIEW OF AN IMPORTANT MODEL DISEASE, SCIENCE PROGRESS 63: 461 (1976).
- KIMBERLIN, R.H., SCRAPIE MOUSE: 1 (1976).
- KLEINKAUF, H, CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY 91: 129 (1981).
- LATARJET, R, SLOW TRANSMISSIBLE D 2: 387 (1979).
- LEWIN, P, SCRAPIE - INFECTIVE PEPTIDE, LANCET 1: 748 (1972).
- MACKAY, JMK, DETECTION OF SCRAPIE AGENT IN TISSUES OF NORMAL MICE, NATURE 219: 182 (1968). · doi:10.1038/219182a0
- MALONE, T.G., MEMBRANE-FREE SCRAPIE ACTIVITY, JOURNAL OF VIROLOGY 25: 933 (1978). · doi:10.1128/jvi.25.3.933-935.1978
- MALONE, T.G., EVIDENCE FOR THE LOW-MOLECULAR WEIGHT NATURE OF SCRAPIE AGENT, NATURE 278: 575 (1979). · doi:10.1038/278575a0
- MANUELIDIS, E.E., SLOW TRANSMISSIBLE D 2: 147 (1979).
- MARSH, R.F., EVIDENCE FOR AN ESSENTIAL DNA COMPONENT IN SCRAPIE AGENT, NATURE 275: 146 (1978). · doi:10.1038/275146a0
- MCKINLEY, M.P., REVERSIBLE CHEMICAL MODIFICATION OF THE SCRAPIE AGENT, SCIENCE 214: 1259 (1981). · doi:10.1126/science.6795721
- MEANS, G.E., CHEM MODIFICATION PR: 1 (1971).
- MFADYEAN, J, J COMP PATHOL 31: 102 (1918). · doi:10.1016/s0368-1742(18)80015-7
- MILLSON, G.C., SLOW VIRUS DIS ANIMA: 243 (1976).
- MOULD, D.L., SCRAPIE IN MICE . STABILITY OF AGENT TO VARIOUS SUSPENDING MEDIA PH AND SOLVENT EXTRACTION, RESEARCH IN VETERINARY SCIENCE 6: 151 (1965). · doi:10.1016/s0034-5288(18)34749-0
- NARANG, H.K., RUTHENIUM RED AND LANTHANUM NITRATE A POSSIBLE TRACER AND NEGATIVE STAIN FOR SCRAPIE PARTICLES, ACTA NEUROPATHOLOGICA 29: 37 (1974). · doi:10.1007/bf00684389
- NOZTH, ACT, NATURE 191: 1242 (1961). · doi:10.1038/1911242a0
- PATTISON, I.H., FURTHER EXPERIMENTAL OBSERVATIONS ON SCRAPIE, JOURNAL OF COMPARATIVE PATHOLOGY AND THERAPEUTICS 71: 350 (1961). · doi:10.1016/s0368-1742(61)80040-4
- PATTISON, I.H., DETECTION OF SCRAPIE AGENT IN TISSUES OF NORMAL MICE WITH SPECIAL REFERENCE TO POSSIBILITY OF ACCIDENTAL LABORATORY CONTAMINATION, RESEARCH IN VETERINARY SCIENCE 12: 30 (1971). · doi:10.1016/s0034-5288(18)34235-8
- PATTISON, I.H., VETERINARY RECORD 80: 1 (1967).
- PHILLIPS, J.H., PROGRESS NUCLEIC ACI 7: 349 (1967).
- PRUSINER, S.B., AGING BRAIN DEMENTIA: 205 (1980).
- PRUSINER, S.B., GEL-ELECTROPHORESIS AND GLASS PERMEATION CHROMATOGRAPHY OF THE HAMSTER SCRAPIE AGENT AFTER ENZYMATIC DIGESTION AND DETERGENT EXTRACTION, BIOCHEMISTRY 19: 4892 (1980). · doi:10.1021/bi00562a029
- PRUSINER, S.B., NEUROCHEMISTRY CLIN: 73 (1980).
- PRUSINER, S.B., ELECTROPHORETIC PROPERTIES OF THE SCRAPIE AGENT IN AGAROSE GELS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 77: 2984 (1980).
- PRUSINER, S.B., SLOW TRANSMISSIBLE D 2: 425 (1979).
- QUALTIERE, L.F., RE-EXAMINATION OF HUMORAL TOLERANCE IN CHICKENS CONGENITALLY INFECTED WITH AN AVIAN-LEUKOSIS VIRUS, JOURNAL OF IMMUNOLOGY 122: 825 (1979). · doi:10.4049/jimmunol.122.3.825
- REYNOLDS, J.A., MEMBRANE RECEPTORS B 11: 33 (1981).
- ROHWER, R.G., SEARCH CAUSE MULTIPL: 333 (1980).
- ROSE, J.A., COMPREHENSIVE VIROLOGY 3: 1 (1974).
- SCHAFFER, F.L., ADV VIRUS RES 6: 159 (1959). · doi:10.1016/s0065-3527(08)60491-1
- SCHUSTER, H, INACTIVATING AND MUTAGENIC ACTION OF HYDROXYLAMINE ON TOBACCO MOSAIC VIRUS RIBONUCLEIC ACID, VIROLOGY 19: 421 (1963). · doi:10.1016/0042-6822(63)90035-7
- 10.1016/0042-6822(73)90224-9 · doi:10.1016/0042-6822(73)90224-9
- SIAKATOS, A.N., DISCOVERY OF A PARTICLE UNIQUE TO BRAIN AND SPLEEN SUBCELLULAR-FRACTIONS FROM SCRAPIE-INFECTED MICE, JOURNAL OF GENERAL VIROLOGY 43: 417 (1979). · doi:10.1099/0022-1317-43-2-417
- SOMERVILLE, R.A., CHANGES IN A PROTEIN-NUCLEIC ACID COMPLEX FROM SYNAPTIC PLASMA-MEMBRANE OF SCRAPIE-INFECTED MOUSE-BRAIN, BIOCHEMICAL SOCIETY TRANSACTIONS 4: 1112 (1976). · doi:10.1042/bst0041112
- 10.1126/science.81.2113.644 · doi:10.1126/science.81.2113.644
- STOCKMAN, S, JOURNAL OF COMPARATIVE PATHOLOGY AND THERAPEUTICS 26: 317 (1913). · doi:10.1016/s0368-1742(13)80060-4
- TESSMAN, I, MUTAGENIC TREATMENT OF DOUBLE- AND SINGLE-STRANDED DNA PHAGES T4 AND S13 WITH HYDROXYLAMINE, VIROLOGY 35: 330 (1968). · doi:10.1016/0042-6822(68)90275-4
- VINOGRAD, J, BUOYANT BEHAVIOR OF VIRAL AND BACTERIAL DNA IN ALKALINE CSCL, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 49: 12 (1963).
- WAKSMAN, B.H., TOLERANCE, THYMUS, AND SUPPRESSOR T-CELLS, CLINICAL AND EXPERIMENTAL IMMUNOLOGY 28: 363 (1977).
- Parry, H. B., Virus Diseases and the Nervous System: 99 (1969).
- WILSON, D.R., STUDIES IN SCRAPIE, JOURNAL OF COMPARATIVE PATHOLOGY AND THERAPEUTICS 60: 267 (1950). · doi:10.1016/s0368-1742(50)80025-5
- YANG, V.W., A SMALL NUCLEAR RIBONUCLEOPROTEIN IS REQUIRED FOR SPLICING OF ADENOVIRAL EARLY RNA SEQUENCES, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES 78: 1371 (1981).
- ZLOTNIK, I, ACTA NEUROPATHOLOGICA 1: 61 (1962).
Cited by
Items 101–200 of 232
Naslavsky, N., Stein, R., Yanai, A., Friedlander, G., & Taraboulos, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6324 · Cited by 395
Balancing Selection at the Prion Protein Gene Consistent with Prehistoric Kurulike Epidemics
Mead, S., Stumpf, M. P. H., Whitfield, J., Beck, J. A., Poulter, M., Campbell, T., Uphill, J. B., Goldstein, D., Alpers, M., Fisher, E. M. C., et al. (2003) · Science · doi:10.1126/science.1083320 · Cited by 394
Bruce, M. E., McConnell, I., Fraser, H., & Dickinson, A. G. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-3-595 · Cited by 388
Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein
Schmitt-Ulms, G., Legname, G., Baldwin, M. A., Ball, H. L., Bradon, N., Bosque, P. J., Crossin, K. L., Edelman, G. M., DeArmond, S. J., Cohen, F. E., et al. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.5183 · Cited by 387
Self-citationNMR structure of the bovine prion protein
López García, F., Zahn, R., Riek, R., & Wüthrich, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.15.8334 · Cited by 385
Statistical Inference as Severe Testing: How to Get Beyond the Statistics Wars
Mayo, D. G. (2018) · doi:10.1017/9781107286184 · Cited by 376
The Seeds of Neurodegeneration: Prion-like Spreading in ALS
Polymenidou, M., & Cleveland, D. W. (2011) · Cell · doi:10.1016/j.cell.2011.10.011 · Cited by 376
Liebman, S. W., & Chernoff, Y. O. (2012) · Genetics · doi:10.1534/genetics.111.137760 · Cited by 372
Hewitt, P. E., Llewelyn, C. A., Mackenzie, J., & Will, R. G. (2006) · Vox Sanguinis · doi:10.1111/j.1423-0410.2006.00833.x · Cited by 370
Molecular classification of sporadic Creutzfeldt–Jakob disease
Hill, A. F., Joiner, S., Wadsworth, J. D. F., Sidle, K. C. L., Bell, J. E., Budka, H., Ironside, J. W., & Collinge, J. (2003) · Brain · doi:10.1093/brain/awg125 · Cited by 367
Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins
Butler, D. A., Scott, M. R., Bockman, J. M., Borchelt, D. R., Taraboulos, A., Hsiao, K. K., Kingsbury, D. T., & Prusiner, S. B. (1988) · Journal of Virology · doi:10.1128/jvi.62.5.1558-1564.1988 · Cited by 366
Self-citationSporadic human prion diseases: molecular insights and diagnosis
Puoti, G., Bizzi, A., Forloni, G., Safar, J. G., Tagliavini, F., & Gambetti, P. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70063-7 · Cited by 365
Neurodegenerative Diseases: Expanding the Prion Concept
Walker, L. C., & Jucker, M. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071714-033828 · Cited by 361
“By the 1980s, Prusiner (1982, 1998) and colleagues had unambiguously demonstrated that the infectious agent consists solely of an abnormally folded protein, for which Prusiner coined the term “prion” (proteinaceous infectious particle).”
BackgroundProtein Misfolding and Neurodegeneration
Soto, C., & Estrada, L. D. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.56 · Cited by 352
Combs, C. K., Johnson, D. E., Cannady, S. B., Lehman, T. M., & Landreth, G. E. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-03-00928.1999 · Cited by 352
Molecular Mechanisms of Prion Pathogenesis
Aguzzi, A., Sigurdson, C., & Heikenwaelder, M. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154326 · Cited by 351
Weissmann, C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1025 · Cited by 346
Purification and properties of the cellular and scrapie hamster prion proteins
TURK, E., TEPLOW, D. B., HOOD, L. E., & PRUSINER, S. B. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb14246.x · Cited by 346
Self-citationPrion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells
Caughey, B., Race, R. E., Ernst, D., Buchmeier, M. J., & Chesebro, B. (1989) · Journal of Virology · doi:10.1128/jvi.63.1.175-181.1989 · Cited by 343
Aronoff-Spencer, E., Burns, C. S., Avdievich, N. I., Gerfen, G. J., Peisach, J., Antholine, W. E., Ball, H. L., Cohen, F. E., Prusiner, S. B., & Millhauser, G. L. (2000) · Biochemistry · doi:10.1021/bi001472t · Cited by 343
Self-citationMolecular Cloning of a Human Prion Protein cDNA
KRETZSCHMAR, H. A., STOWRING, L. E., WESTAWAY, D., STUBBLEBINE, W. H., PRUSINER, S. B., & DEARMOND, S. J. (1986) · DNA · doi:10.1089/dna.1986.5.315 · Cited by 342
Self-citationElevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease
Otto, M., Wiltfang, J., Tumani, H., Zerr, I., Lantsch, M., Kornhuber, J., Weber, T., Kretzschmar, H. A., & Poser, S. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00215-2 · Cited by 341
Insights into prion strains and neurotoxicity
Aguzzi, A., Heikenwalder, M., & Polymenidou, M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2204 · Cited by 329
Prusiner, S. B., & Hsiao, K. K. (1994) · Annals of Neurology · doi:10.1002/ana.410350404 · Cited by 328
Self-citationSaá, P., Castilla, J., & Soto, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603964200 · Cited by 328
Regional mapping of prion proteins in brain.
Taraboulos, A., Jendroska, K., Serban, D., Yang, S. L., DeArmond, S. J., & Prusiner, S. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7620 · Cited by 327
Self-citationMolecular architecture of human prion protein amyloid: A parallel, in-register β-structure
Cobb, N. J., Sönnichsen, F. D., Mchaourab, H., & Surewicz, W. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706522104 · Cited by 326
Mead, S. (2006) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201544 · Cited by 325
Biological Evidence that Scrapie Agent Has an Independent Genome
Bruce, M. E., & Dickinson, A. G. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-1-79 · Cited by 325
Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration
Goedert, M., Masuda-Suzukake, M., & Falcon, B. (2017) · Brain · doi:10.1093/brain/aww230 · Cited by 323
Getting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions
Caughey, B., Baron, G. S., Chesebro, B., & Jeffrey, M. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145410 · Cited by 323
Chronic Wasting Disease of Deer and Elk: A Review with Recommendations for Management
Williams, E. S., Miller, M. W., Kreeger, T. J., Kahn, R. H., & Thorne, E. T. (2002) · The Journal of Wildlife Management · doi:10.2307/3803123 · Cited by 322
Prions, prionoids and protein misfolding disorders
Scheckel, C., & Aguzzi, A. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0011-4 · Cited by 321
Prion propagation and toxicity in vivo occur in two distinct mechanistic phases
Sandberg, M. K., Al-Doujaily, H., Sharps, B., Clarke, A. R., & Collinge, J. (2011) · Nature · doi:10.1038/nature09768 · Cited by 319
Soil, food security and human health: a review
Oliver, M. A., & Gregory, P. J. (2015) · European Journal of Soil Science · doi:10.1111/ejss.12216 · Cited by 311
Propagation of Protein Aggregation in Neurodegenerative Diseases
Vaquer-Alicea, J., & Diamond, M. I. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045049 · Cited by 310
A 'unified theory' of prion propagation
Weissmann, C. (1991) · Nature · doi:10.1038/352679a0 · Cited by 305
Amyloid Structure: Conformational Diversity and Consequences
Toyama, B. H., & Weissman, J. S. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-090908-120656 · Cited by 304
Diversity of oligosaccharide structures linked to asparagines of the scrapie prion protein
Endo, T., Groth, D., Prusiner, S. B., & Kobata, A. (1989) · Biochemistry · doi:10.1021/bi00447a017 · Cited by 304
Self-citationDe Novo Design of Helical Bundles as Models for Understanding Protein Folding and Function
Hill, R. B., Raleigh, D. P., Lombardi, A., & DeGrado, W. F. (2000) · Accounts of Chemical Research · doi:10.1021/ar970004h · Cited by 300
Species-barrier-independent prion replication in apparently resistant species
Hill, A. F., Joiner, S., Linehan, J., Desbruslais, M., Lantos, P. L., & Collinge, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10248 · Cited by 295
A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration
Walsh, D. M., & Selkoe, D. J. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.13 · Cited by 294
Chemical chaperones interfere with the formation of scrapie prion protein.
Tatzelt, J., Prusiner, S. B., & Welch, W. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01027.x · Cited by 294
Self-citationKitamoto, T., Muramoto, T., Mohri, S., Doh-Ura, K., & Tateishi, J. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.6292-6295.1991 · Cited by 294
Identification of prion amyloid filaments in scrapie-infected brain
Dearmond, S. J., McKinley, M. P., Barry, R. A., Braunfeld, M. B., McColloch, J. R., & Prusinert, S. B. (1985) · Cell · doi:10.1016/0092-8674(85)90076-5 · Cited by 294
Prion-like disorders: blurring the divide between transmissibility and infectivity
Cushman, M., Johnson, B. S., King, O. D., Gitler, A. D., & Shorter, J. (2010) · Journal of Cell Science · doi:10.1242/jcs.051672 · Cited by 289
Exosomes in the Pathology of Neurodegenerative Diseases
Howitt, J., & Hill, A. F. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.757955 · Cited by 288
Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters
Bessen, R. A., & Marsh, R. F. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-2-329 · Cited by 287
Glycosylinositol Phospholipid Anchors of the Scrapie and Cellular Prion Proteins Contain Sialic Acid
Stahl, N., Baldwin, M., Hecker, R., Pan, K.-M., Burlingame, A., & Prusiner, S. (1992) · Biochemistry · doi:10.1021/bi00136a600 · Cited by 285
Self-citationA hypothalamic neuronal cell line persistently infected with scrapie prions exhibits apoptosis
Schätzl, H. M., Laszlo, L., Holtzman, D. M., Tatzelt, J., DeArmond, S. J., Weiner, R. I., Mobley, W. C., & Prusiner, S. B. (1997) · Journal of Virology · doi:10.1128/jvi.71.11.8821-8831.1997 · Cited by 282
Self-citationHsiao, K. K., Groth, D., Scott, M., Yang, S. L., Serban, H., Rapp, D., Foster, D., Torchia, M., Dearmond, S. J., & Prusiner, S. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9126 · Cited by 282
Self-citationBiology and Pathogenesis of Lentiviruses
Narayan, O., & Clements, J. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-7-1617 · Cited by 282
Serial propagation of distinct strains of Aβ prions from Alzheimer’s disease patients
Watts, J. C., Condello, C., Stöhr, J., Oehler, A., Lee, J., DeArmond, S. J., Lannfelt, L., Ingelsson, M., Giles, K., & Prusiner, S. B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408900111 · Cited by 282
Self-citationVan Melckebeke, H., Wasmer, C., Lange, A., AB, E., Loquet, A., Böckmann, A., & Meier, B. H. (2010) · Journal of the American Chemical Society · doi:10.1021/ja104213j · Cited by 281
Amyloid aggregates of the HET-s prion protein are infectious
Maddelein, M.-L., Dos Reis, S., Duvezin-Caubet, S., Coulary-Salin, B., & Saupe, S. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072199199 · Cited by 281
The prion hypothesis in Parkinson's disease: braak to the future
Visanji, N. P., Brooks, P. L., Hazrati, L.-N., & Lang, A. E. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-2 · Cited by 278
Deadly Conformations—Protein Misfolding in Prion Disease
Horwich, A. L., & Weissman, J. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80232-9 · Cited by 278
Molecular biology and pathogenesis of prion diseases
PRUSINER, S. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10063-3 · Cited by 278
Self-citationSimulation-based model selection for dynamical systems in systems and population biology
Toni, T., & Stumpf, M. P. H. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp619 · Cited by 260
Synthesis and trafficking of prion proteins in cultured cells.
Taraboulos, A., Raeber, A. J., Borchelt, D. R., Serban, D., & Prusiner, S. B. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.8.851 · Cited by 275
Self-citationRecombinant prion protein induces a new transmissible prion disease in wild-type animals
Makarava, N., Kovacs, G. G., Bocharova, O., Savtchenko, R., Alexeeva, I., Budka, H., Rohwer, R. G., & Baskakov, I. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0633-x · Cited by 275
Prion strain discrimination using luminescent conjugated polymers
Sigurdson, C. J., Nilsson, K. P. R., Hornemann, S., Manco, G., Polymenidou, M., Schwarz, P., Leclerc, M., Hammarström, P., Wüthrich, K., & Aguzzi, A. (2007) · Nature Methods · doi:10.1038/nmeth1131 · Cited by 273
Prion protein expression and superoxide dismutase activity
BROWN, D. R., & BESINGER, A. (1998) · Biochemical Journal · doi:10.1042/bj3340423 · Cited by 271
A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes
Le Dur, A., Béringue, V., Andréoletti, O., Reine, F., Laï, T. L., Baron, T., Bratberg, B., Vilotte, J.-L., Sarradin, P., Benestad, S. L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502296102 · Cited by 269
Consequences of manganese replacement of copper for prion protein function and proteinase resistance
Brown, D. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.6.1180 · Cited by 269
Stahl, N., Borchelt, D. R., & Prusiner, S. B. (1990) · Biochemistry · doi:10.1021/bi00474a028 · Cited by 266
Self-citationBeekes, M., Lasch, P., & Naumann, D. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2007.04.010 · Cited by 266
The biological function of the cellular prion protein: an update
Wulf, M.-A., Senatore, A., & Aguzzi, A. (2017) · BMC Biology · doi:10.1186/s12915-017-0375-5 · Cited by 265
Doh-ura, K., Tateishi, J., Sasaki, H., Kitamoto, T., & Sakaki, Y. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92317-6 · Cited by 264
A systematic review of prion therapeutics in experimental models
Trevitt, C. R. (2006) · Brain · doi:10.1093/brain/awl150 · Cited by 263
Disease-Associated Prion Protein Oligomers Inhibit the 26S Proteasome
Kristiansen, M., Deriziotis, P., Dimcheff, D. E., Jackson, G. S., Ovaa, H., Naumann, H., Clarke, A. R., van Leeuwen, F. W. B., Menéndez-Benito, V., Dantuma, N. P., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.001 · Cited by 263
Moriyama, H., Edskes, H. K., & Wickner, R. B. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8916-8922.2000 · Cited by 261
The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
Rey, N. L., Wesson, D. W., & Brundin, P. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.013 · Cited by 257
Telling, G. C., Haga, T., Torchia, M., Tremblay, P., DeArmond, S. J., & Prusiner, S. B. (1996) · Genes & Development · doi:10.1101/gad.10.14.1736 · Cited by 258
Self-citationMechanisms of Cell-to-Cell Transmission of Pathological Tau: A Review
Gibbons, G. S., Lee, V. M. Y., & Trojanowski, J. Q. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.2505 · Cited by 257
Gomi, H., Yokoyama, T., Fujimoto, K., Ikeda, T., Katoh, A., Itoh, T., & Itohara, S. (1995) · Neuron · doi:10.1016/0896-6273(95)90238-4 · Cited by 256
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome
Goldgaber, D., Goldfarb, L. G., Brown, P., Asher, D. M., Brown, W. T., Lin, S., Teener, J. W., Feinstone, S. M., Rubenstein, R., & Kascsak, R. J. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90095-2 · Cited by 256
Antibodies to a scrapie prion protein
Bendheim, P. E., Barry, R. A., DeArmond, S. J., Stites, D. P., & Prusiner, S. B. (1984) · Nature · doi:10.1038/310418a0 · Cited by 254
Self-citationGenetics of amyotrophic lateral sclerosis: A review
Mathis, S., Goizet, C., Soulages, A., Vallat, J.-M., & Masson, G. L. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.02.030 · Cited by 253
Atypical/Nor98 scrapie: properties of the agent, genetics, and epidemiology
Benestad, S. L., Arsac, J.-N., Goldmann, W., & Nöremark, M. (2008) · Veterinary Research · doi:10.1051/vetres:2007056 · Cited by 253
Normal host prion protein (PrP C ) is required for scrapie spread within the central nervous system
Brandner, S., Raeber, A., Sailer, A., Blättler, T., Fischer, M., Weissmann, C., & Aguzzi, A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13148 · Cited by 252
Are synucleinopathies prion-like disorders?
Angot, E., Steiner, J. A., Hansen, C., Li, J.-Y., & Brundin, P. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70213-1 · Cited by 251
Role of microglia in neuronal cell death in prion disease
Giese, A., Brown, D. R., Groschup, M. H., Feldmann, C., Haist, I., & Kretzschmar, H. A. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00167.x · Cited by 239
“PrP Sc is the only molecule consistently found in infectious preparations and is believed to be the main if not the only component of the transmissible agent which has been termed prion (23, 24, 26).”
BackgroundToledo, J. B., Van Deerlin, V. M., Lee, E. B., Suh, E., Baek, Y., Robinson, J. L., Xie, S. X., McBride, J., Wood, E. M., Schuck, T., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.06.003 · Cited by 234
“…are identified as a result of the study of brain and DNA samples, and biobanks enable the collection of tissue and biofluid samples to accelerate the discovery of pathological subtypes and DNA to make associations between certain pathological subtypes with specific genetic abnormalities [1–6].”
BackgroundSome Speculations about Prions, Amyloid, and Alzheimer's Disease
Prusiner, S. B. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403083101021 · Cited by 213
Self-citationGoedert, M., & Spillantini, M. G. (2017) · Molecular Brain · doi:10.1186/s13041-017-0298-7 · Cited by 213
The role of extracellular vesicles in neurodegenerative diseases
Quek, C., & Hill, A. F. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.090 · Cited by 213
Coleman, B. M., & Hill, A. F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.007 · Cited by 208
A Novel Protective Prion Protein Variant that Colocalizes with Kuru Exposure
Mead, S., Whitfield, J., Poulter, M., Shah, P., Uphill, J., Campbell, T., Al-Dujaily, H., Hummerich, H., Beck, J., Mein, C. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809716 · Cited by 224
Chen, J. J., Nathaniel, D. L., Raghavan, P., Nelson, M., Tian, R., Tse, E., Hong, J. Y., See, S. K., Mok, S.-A., Hein, M. Y., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009432 · Cited by 170
Prion-like spread of protein aggregates in neurodegeneration
Polymenidou, M., & Cleveland, D. W. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120741 · Cited by 184
Lövestam, S., Schweighauser, M., Matsubara, T., Murayama, S., Tomita, T., Ando, T., Hasegawa, K., Yoshida, M., Tarutani, A., Hasegawa, M., et al. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13110 · Cited by 183
Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151
The prion hypothesis: from biological anomaly to basic regulatory mechanism
Tuite, M. F., & Serio, T. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3007 · Cited by 146
Hartmann, K., Sepulveda-Falla, D., Rose, I. V. L., Madore, C., Muth, C., Matschke, J., Butovsky, O., Liddelow, S., Glatzel, M., & Krasemann, S. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0735-1 · Cited by 141
“Prion diseases are characterized by the conformational conversion of the cellular prion protein PrP into the disease associated protein isoform PrP which is key to prion formation and disease progression [52].”
BackgroundIntercellular Spread of Protein Aggregates in Neurodegenerative Disease
Davis, A. A., Leyns, C. E. G., & Holtzman, D. M. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062636 · Cited by 131
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Brás, I. C., & Outeiro, T. F. (2021) · Cells · doi:10.3390/cells10020375 · Cited by 136
Induction of a transmissible tau pathology by traumatic brain injury
Zanier, E. R., Bertani, I., Sammali, E., Pischiutta, F., Chiaravalloti, M. A., Vegliante, G., Masone, A., Corbelli, A., Smith, D. H., Menon, D. K., et al. (2018) · Brain · doi:10.1093/brain/awy193 · Cited by 136
Borchelt, D. R., Koliatsos, V. E., Guarnieri, M., Pardo, C. A., Sisodia, S. S., & Price, D. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36683-8 · Cited by 132
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124
Metadata
- Authors
- Prusiner, S. B.
- Venue
- Science
- Published
- 1982-04-09
- Volume
- 216
- Issue
- 4542
- Pages
- 136-144
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2013679718
- Cited by
- 5,118
- References
- 83
- FWCI
- 17.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.